Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma

Letrozole vs observation for HR positive breast cancer

Comment: Nivolumab-based treatment halts melanoma progression

Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

Preventive neck lymph node surgery improves early oral cancer survival

Preventive neck lymph node surgery improves early oral cancer survival

Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

Improved care has extended lifespan of childhood cancer survivors since the 1970s

Phase III study finds initial nivolumab-based treatment halts melanoma progression